Mr President, Commissioner, I should like to take the floor briefly, first of all, to congratulate everyone who worked on this subject, and then to express my surprise, nonetheless, that one point has been overlooked, namely cross-pharmacovigilance.
Signor Presidente, signor Commissario, intervengo brevemente per congratularmi con quanti hanno collaborato alla presente relazione e per esprimere la mia sorpresa sull ’ omissione di un tema: la farmacovigilanza incrociata.